Related Experiment Video
Updated: Nov 12, 2025

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
EGR-1 plays a protective role in AMPK inhibitor compound C-induced apoptosis through ROS-induced ERK activation in
Kai-Cheng Chuang1, Fan-Wen Chen1, Meng-Hsiun Tsai2,3
1Institute of Biomedical Sciences, National Chung Hsing University, Taichung 402, Taiwan, R.O.C.
Abstract:
Skin cancer is caused by abnormal proliferation, gene regulation and mutation of epidermis cells. Compound C is commonly used as an inhibitor of AMP-activated protein kinase (AMPK), which serves as an energy sensor in cells. Recently, compound C has been reported to induce apoptotic and autophagic death in various skin cancer cell lines via an AMPK-independent pathway. However, the signaling pathways activated in compound C-treated cancer cells remain unclear. The present oligodeoxynucleotide-based microarray screening assay showed that the mRNA expression of the zinc-finger transcription factor early growth response-1 (EGR-1), which helps regulate cell cycle progression and cell survival, was significantly upregulated in compound C-treated skin cancer cells. Compound C was demonstrated to induce EGR-1 mRNA and protein expression in a time and dose-dependent manner. Confocal imaging showed that compound C-induced EGR-1 protein expression was localized in the nucleus. Compound C was demonstrated to activate extracellular signal-regulated kinase (ERK) phosphorylation. Inhibition of this compound C-induced ERK phosphorylation downregulated the mRNA and protein expression of EGR-1. In addition, removal of compound C-induced reactive oxygen species (ROS) not only decreased ERK phosphorylation, but also inhibited compound C-induced EGR-1 expression. A functional assay showed that knock down of EGR-1 expression in cancer cells decreased the survival rate while also increasing caspase-3 activity and apoptotic marker expression after compound C treatment. However, no difference in autophagy marker light chain 3-II protein expression was observed between compound C-treated control cells and EGR-1-knockdown cells. Thus, it was concluded that that EGR-1 may antagonize compound C-induced apoptosis but not compound C-induced autophagy through the ROS-mediated ERK activation pathway.
Insights
Compound C induces skin cancer cell death via a novel pathway involving early growth response-1 (EGR-1) and extracellular signal-regulated kinase (ERK) activation. EGR-1 antagonizes apoptosis but not autophagy, offering new therapeutic targets for skin cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Skin cancer arises from uncontrolled epidermal cell growth, mutation, and gene dysregulation.
- Compound C, an AMP-activated protein kinase (AMPK) inhibitor, induces apoptosis and autophagy in skin cancer cells through AMPK-independent mechanisms.
- The precise signaling pathways triggered by Compound C in cancer cells remain largely unknown.
Purpose of the Study:
- To elucidate the signaling pathways activated by Compound C in skin cancer cells.
- To investigate the role of early growth response-1 (EGR-1) in Compound C-induced cell death.
- To determine the relationship between EGR-1, reactive oxygen species (ROS), and extracellular signal-regulated kinase (ERK) signaling.
Main Methods:
- Oligodeoxynucleotide-based microarray screening to identify differentially expressed genes.
- Quantitative real-time PCR and Western blotting to assess mRNA and protein expression.
- Confocal microscopy for protein localization, and functional assays including gene knockdown and reactive oxygen species scavenging.
Main Results:
- Compound C significantly upregulated early growth response-1 (EGR-1) mRNA and protein in a time- and dose-dependent manner, with nuclear localization.
- Compound C activated extracellular signal-regulated kinase (ERK) phosphorylation; inhibiting ERK or scavenging reactive oxygen species (ROS) reduced EGR-1 expression.
- EGR-1 knockdown in cancer cells decreased survival and increased caspase-3 activity and apoptosis markers post-Compound C treatment, but did not affect autophagy markers.
Conclusions:
- Early growth response-1 (EGR-1) antagonizes Compound C-induced apoptosis in skin cancer cells.
- This antagonism is mediated through a pathway involving reactive oxygen species (ROS) and extracellular signal-regulated kinase (ERK) activation.
- EGR-1 does not appear to influence Compound C-induced autophagy, suggesting distinct roles in Compound C's cytotoxic effects.
Related Concept Videos
MAPK Signaling Cascades
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

